Later studies using the peroxiredoxin-2 peptide-derived vaccine demonstrated a 60–70% protection against early-stage L. salmonis experimental infection and 92% reduction in the number of adult lice in C. rogercresseyi but only for a short period of time and with significant loss of lice throughout the experiment (25). This evidence concerns the gene PRDX2 and infection.